Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.19.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at beginning at Jun. 30, 2017 $ 19,075 $ 31,499,889 $ (16,508,057) $ 15,010,907
Balance at beginning (in shares) at Jun. 30, 2017 19,075,050      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued for cash, net of issuance costs
Common stock issued for cash, net of issuance costs (in shares)      
Common stock issued for services $ 100 536,895 536,995
Common stock issued for services (in shares) 100,000      
Common stock issued for exercise of warrants $ 10 47,655 47,665
Common stock issued for exercise of warrants (in shares) 9,533      
Vesting of restricted shares 117,045 117,045
Net loss     (4,643,198) (4,643,198)
Balance at ending at Sep. 30, 2017 $ 19,185 32,201,484 (21,151,255) 11,069,414
Balance at ending (in shares) at Sep. 30, 2017 19,184,583      
Balance at beginning at Jun. 30, 2017 $ 19,075 31,499,889 (16,508,057) 15,010,907
Balance at beginning (in shares) at Jun. 30, 2017 19,075,050      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (14,986,254)
Balance at ending at Mar. 31, 2018 $ 22,232 48,211,327 (31,494,311) 16,739,248
Balance at ending (in shares) at Mar. 31, 2018 22,232,200      
Balance at beginning at Sep. 30, 2017 $ 19,185 32,201,484 (21,151,255) 11,069,414
Balance at beginning (in shares) at Sep. 30, 2017 19,184,583      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued for cash, net of issuance costs $ 3,183 13,254,880 13,258,063
Common stock issued for cash, net of issuance costs (in shares) 3,183,269      
Warrants issued to underwriter (645,757) (645,757)
Common stock issued for services $ 11 2,043,816 2,043,827
Common stock issued for services (in shares) 11,000      
Vesting of restricted shares (254,824) (254,824)
Repurchase of common shares $ (58) 58    
Repurchase of common shares (in shares) (58,152)      
Net loss     (5,540,416) (5,540,416)
Balance at ending at Dec. 31, 2017 $ 22,321 $ 46,599,657 (26,691,671) $ 19,930,307
Balance at ending (in shares) at Dec. 31, 2017 22,320,700      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued for cash, net of issuance costs (in shares)   (58,133)   (58,133)
Common stock issued for services $ 20 $ 1,693,246 $ 1,693,266
Common stock issued for services (in shares) 20,000      
Common stock issued for exercise of warrants $ 2 2,998   3,000
Common stock issued for exercise of warrants (in shares) 2,000      
Vesting of restricted shares   (26,552)   (26,552)
Repurchase of common shares $ (111) 111
Repurchase of common shares (in shares) (110,500)      
Net loss     (4,802,640) (4,802,640)
Balance at ending at Mar. 31, 2018 $ 22,232 48,211,327 (31,494,311) 16,739,248
Balance at ending (in shares) at Mar. 31, 2018 22,232,200      
Balance at beginning at Jun. 30, 2018 $ 22,203 52,074,343 (38,226,268) $ 13,849,862
Balance at beginning (in shares) at Jun. 30, 2018 22,203,437     22,203,437
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued for cash, net of issuance costs   (80,944)   $ (80,944)
Common stock issued for services $ 112 1,946,916 1,947,028
Common stock issued for services (in shares) 111,875      
Common stock issued for exercise of warrants $ 19 70,501   70,520
Common stock issued for exercise of warrants (in shares) 19,086      
Vesting of restricted shares   351,035   351,035
Common stock issued in payment of note interest $ 40 289,750   289,790
Common stock issued in payment of note interest (in shares) 40,024      
Net loss     (7,307,699) (7,307,699)
Balance at ending at Sep. 30, 2018 $ 22,374 54,651,601 (45,533,967) 9,140,008
Balance at ending (in shares) at Sep. 30, 2018 22,374,422      
Balance at beginning at Jun. 30, 2018 $ 22,203 52,074,343 (38,226,268) $ 13,849,862
Balance at beginning (in shares) at Jun. 30, 2018 22,203,437     22,203,437
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       $ (23,486,935)
Balance at ending at Mar. 31, 2019 $ 30,008 91,383,199 (61,713,203) $ 29,700,004
Balance at ending (in shares) at Mar. 31, 2019 30,008,412     30,008,412
Balance at beginning at Sep. 30, 2018 $ 22,374 54,651,601 (45,533,967) $ 9,140,008
Balance at beginning (in shares) at Sep. 30, 2018 22,374,422      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued for cash, net of issuance costs $ 7,362 28,732,750 28,740,112
Common stock issued for cash, net of issuance costs (in shares) 7,362,365      
Common stock issued for services $ 121 1,044,195   1,044,316
Common stock issued for services (in shares) 120,744      
Intrinsic value of beneficial conversion feature   3,950,839   3,950,839
Vesting of restricted shares   177,693   177,693
Common stock issued in payment of note interest $ 53 243,697   243,750
Common stock issued in payment of note interest (in shares) 52,922      
Net loss     (6,745,325) (6,745,325)
Balance at ending at Dec. 31, 2018 $ 29,910 88,800,775 (52,279,292) 36,551,393
Balance at ending (in shares) at Dec. 31, 2018 29,910,453      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued for cash, net of issuance costs $ 1 (1)    
Common stock issued for cash, net of issuance costs (in shares) 1,227      
Common stock issued for services $ 46 2,125,610 2,125,656
Common stock issued for services (in shares) 46,000      
Common stock issued for exercise of warrants $ 16 (28)   (12)
Common stock issued for exercise of warrants (in shares) 15,697      
Common stock issued for exercise of options $ 19 133,481   133,500
Common stock issued for exercise of options (in shares) 18,750      
Vesting of restricted shares   79,633   79,633
Repurchase of common shares $ (22) 22    
Repurchase of common shares (in shares) (21,125)      
Common stock issued in payment of note interest $ 38 243,707   243,745
Common stock issued in payment of note interest (in shares) 37,410      
Net loss     (9,433,911) (9,433,911)
Balance at ending at Mar. 31, 2019 $ 30,008 $ 91,383,199 $ (61,713,203) $ 29,700,004
Balance at ending (in shares) at Mar. 31, 2019 30,008,412     30,008,412